---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-26-000037"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2026-08-11T10:47:32+00:00"
generated_at: "2026-08-11T10:50:08.719732+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q4 revenue up 6% to $63.7B; FY26 non-GAAP EPS $11.26, up 37%

## Summary
- Q4 revenue $63.7B (+6% YoY); GAAP diluted EPS $1.70 (+70%); non-GAAP EPS $2.91 (+40%), incl. $0.31 IEEPA refund.
- FY26 revenue $254.2B (+14%); non-GAAP EPS $11.26 (+37%); excluding IEEPA refund, EPS $10.95 (+33%).
- Board approved $5.0B incremental buyback; FY26 repurchases totaled $1.4B, new authorization $6.4B.
- FY27 guidance: non-GAAP EPS $12.40-$12.60 (+13% to +15%); segment profit growth guided 8-18%.
- Pharma segment profit +21%; GMPD profit $150M on IEEPA refunds; dividend $0.5158/share payable Oct 15.

## SEC filing metadata
- accession: 0000721371-26-000037
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2026-08-11T10:47:32+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/0000721371-26-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/cah-20260811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-26-000037
- JSON: https://secwatch.observer/filing/0000721371-26-000037.json
- Plain text: https://secwatch.observer/filing/0000721371-26-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.